Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 944-092-9 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Acute Toxicity: oral
Some information in this page has been claimed confidential.
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1991-05-08 to 1991-05-24
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Test material form:
- solid: particulate/powder
- Details on test material:
- Direct Red 83:1
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
Male and female Sprague-Dawley strain rats were supplied by Charles River (UK) Ltd., Manston, Kent, U.K. At the start of the main study the males weighed 136 -155 g, and the females 135-148 g, and were approximately five to eight weeks old. After a minimum acclimatization period of at least five days the animals were selected at random and given a unique number within the study by indelible ink marking on the tail and a number written on a cage card.
HUSBANDRY:
The animals were housed in groups of five by sex in solid-floor polypropylene cages with sawdust bedding. With the exception of an overnight fast immediately before dosing and for approximately two hours after dosing, free access to mains drinking water and food (Rat and Mouse Expanded Diet N0. 1, Special Diet Services Limited, Witham, Essex, U.K.) was allowed throughout the study.
The animal room was maintained at a temperature of 21 - 24 °C and relative humidity of 36 - 62%.
The rate of air exchange was approx. 15 changes per hour and the lighting was controlled by a time switch to give 12 hours continuous light and 12 hours darkness.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- arachis oil
- Details on oral exposure:
- VEHICLE (arachis oil)
Single oral dose as suspension in arachis oil
- Amount of vehicle (if gavage): NA
- Justification for choice of vehicle: solubility of test material - Doses:
- Range finding-Study
A range-finding study was performed to establish a dosing regima as follows:
Dose level mg/L Concentration mg/L Dose volume mL/Kg Number of Rats
2000 200 10 1(male) 1(female)
Main-study
Based on the results of the range-finding study a further group of animals was treated as follows:
Dose level mg/L Concentration mg/L Dose volume mL/K Number of Rats
2000 200 10 5 (male) 5(female) - No. of animals per sex per dose:
- 5 males (136 – 155 g) 2000mg/L single dose
5 females (135 – 148 g) 2000mg/L single dose
Approx. 5 – 8 weeks old - Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: All animals were dose once only by gavage using a metal cannula attached to graduated syringe.
Deaths and other sign of toxicity were recorded 1, 1, 2 and 4 hours after dosing and subsequently once daily for 14 days.
Individual bodyweights were recorded on the day of treatment (day 0) and on day 7 and 14
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, and histopathology. - Statistics:
- DATA EVALUATION:
Data evaluation included the relationship if any, between the animals’ exposure of the test material and the incidence of severity of all abnormalities including behavioral and clinical observations, gross lesions, bodyweight changes, mortality and any other toxicological effects.
Using the mortality data obtained and estimate according to the acute oral median dose (LD50) of the test material was made.
Results and discussion
- Preliminary study:
- RANGE FINDING STUDY
A range finding study was performed to establish a dosing regime as follows:
Dose level (mg/kg) Concentration (mg/mL) Dose volume (mL/kg) Number of Rates
2000 200 10 1 Male 1 Female
Death and overt signs of toxicity were recorded 1/2, 1, 2 and 4 hours after dosing and the daily for five days.
Individual bodyweights were recorded on the day of dosing to allow calculation of individual treatment volumes. No necropsies were performed.
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No deaths,
No abnormalities at necropsy - Clinical signs:
- other: No signs of systemic toxicity were noted during the study.
Any other information on results incl. tables
No deaths
No signs of systemic toxicity
All animals showed expected gain in bodyweight
No abnormalities at necropsy
TableI: INDIVIDUAL CLINICAL OBSERVATIONS AND MORTALITY DATA IN THE RANGE_FINDING STUDY |
||||||||||
Dose level (mg/kg) |
Animal Number & Sex |
Effects Noted after Dosing (Hours) |
Effects Noted During Period After Dosing (Days) |
|||||||
2000 |
1-0 Male |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2-0 Female |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0= no signs of systemic toxicity were noted during the study.
TableII: INDIVIDUAL CLINICAL OBSERVATIONS AND MORTALITY DATA IN THE MAIN STUDY |
|||||||||||||||||||
Dose level (mg/kg)
|
Animal Number & Sex
|
Effects Noted after Dosing (Hours)
|
Effects Noted During Period After Dosing (Days)
|
||||||||||||||||
2000 |
3-0 Male |
1/2 |
1 |
2 |
4 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
3-1 Male |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
3-2 Male |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
3-3 Male |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
3-4 Male |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
4-0 Female |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
4-1 Female |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
4-2 Female |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
4-3 Female |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
4-4 Female |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0= no signs of systemic toxicity were noted during the study.
TableIII: INDIVIDUAL NECROPSY FINDINGS IN THE MAIN STUDY |
|||
|
|||
Dose level (mg/kg)
|
Animal Number & Sex
|
Macroscopic observations
|
|
2000 |
3-0 Male |
Killed day 14 |
No abnormalities detected |
3-1 Male |
Killed day 14 |
No abnormalities detected |
|
3-2 Male |
Killed day 14 |
No abnormalities detected |
|
3-3 Male |
Killed day 14 |
No abnormalities detected |
|
3-4 Male |
Killed day 14 |
No abnormalities detected |
|
4-0 Female |
Killed day 14 |
No abnormalities detected |
|
4-1 Female |
Killed day 14 |
No abnormalities detected |
|
4-2 Female |
Killed day 14 |
No abnormalities detected |
|
4-3 Female |
Killed day 14 |
No abnormalities detected |
|
4-4 Female |
Killed day 14 |
No abnormalities detected |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute oral lethal median dose (LD50) of Direct Red 83:1 in the Sprague-Dawley strain Rat was found to be greater than 2000 mg/kg bodyweight
-no symbol and risk phrase are required according to CLP labelling regulations - Executive summary:
A study was performed to assess the acute oral toxicity of Direct Red 83:1 in the Sprague-Dawley strain rat. The method used followed that described in the OECD Guidelines for Testing of Chemicals (1981) No. 401 “Acute Oral Toxicity” referenced as Method B1 in Commission Directives 84/449/EEC (which constitutes Annex V of Council Directive 67/548/EEC).
The results may be used as a basic for classification and labelling under Annex VI of Council Directive 67/548/EEC (as adapted to technical progress by Commission Directive 83/467/EEC).
Following a range-finding study, a group of 10 fasted animals (five males and five females) was given a single oral dose of Direct Red 83:1, as a suspension in arachis oil B.P.at a dose level of 2000 mg/kg bodyweight. The animals were observed for fourteen days after the day of dosing and were then killed for gross pathological examination.
There were no deaths. No signs of systemic toxicity were noted during the study.
All animals showed expected gain in bodyweight during the study.
No abnormalities were noted at necropsy.
The acute oral median lethal dose (LD50) of the test material in the Sprague-Dawley strain rat was found to be greater than 2000 mg/kg body weight.
No symbol and risk phrase are required according to EEC labelling regulations.
.
Results Synopsis and test report:
Species
Strain
Origin
Sex of animals dosed
Tabulation of response data by dose level
LD50 Value
Findings
Sprague Dawley rats
HSD: Sprague Dawley SD
Charles River (U.K.) Ltd., Manston, Kent. U.K.
Male and female
No animals died during the test.
>2000 mg/kg body weight
The animals killed at the end of the observation period showed no macroscopically visible changes.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)
Embora a ECHA disponibilize muito material em linha na sua língua, uma parte desta página está disponível apenas em inglês. Mais informações sobreas práticas de multilinguismo da ECHA.
Bem-vindo ao sítio Web da ECHA O navegador Internet Explorer 7 (e versões anteriores) não é totalmente suportado por este sítio Web. Por favor atualize o seu Internet Explorer para uma versão mais recente.
Este sítio Web utiliza cookies a fim de garantir a melhor experiência possível nos nossos sítios Web.
Saiba mais sobre como utilizar cookies.